Clinicopathological significance of CD133 in lung cancer: A meta-analysis.
about
SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinomaPrognostic value of cancer stem cell marker CD133 in ovarian cancer: a meta-analysisHigh CD133 expression in the nucleus and cytoplasm predicts poor prognosis in non-small cell lung cancerPrognostic value of cancer stem cell marker CD133 expression in esophageal carcinoma: A meta-analysis.The role of cancer stem cells in tumor heterogeneity and resistance to therapy.Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
P2860
Clinicopathological significance of CD133 in lung cancer: A meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinicopathological significance of CD133 in lung cancer: A meta-analysis.
@en
Clinicopathological significance of CD133 in lung cancer: A meta-analysis.
@nl
type
label
Clinicopathological significance of CD133 in lung cancer: A meta-analysis.
@en
Clinicopathological significance of CD133 in lung cancer: A meta-analysis.
@nl
prefLabel
Clinicopathological significance of CD133 in lung cancer: A meta-analysis.
@en
Clinicopathological significance of CD133 in lung cancer: A meta-analysis.
@nl
P2093
P2860
P356
P1476
Clinicopathological significance of CD133 in lung cancer: A meta-analysis.
@en
P2093
P2860
P304
P356
10.3892/MCO.2013.195
P577
2013-09-30T00:00:00Z